饮食失调

{"title":"饮食失调","authors":"","doi":"10.1016/j.mpmed.2024.05.011","DOIUrl":null,"url":null,"abstract":"<div><p>Eating disorders are common, affecting 5–10% of young people, with &gt;50% of these having an illness that persists for &gt;5 years. The main eating disorders are anorexia nervosa, bulimia nervosa and binge-eating disorder. Eating disorders with binge eating now dominate. New diagnostic categories have been introduced (avoidant/restrictive food intake disorder, pica, rumination disorder). Genetic factors interacting with environmental stress (some shared with other psychiatric disorders, others relating to metabolism and eating) increase the risk. Self-management strategies, including a focus on social emotional functioning and behavioural change skills to manage fears and habits, are moderately effective. Olanzapine shows some evidence in anorexia nervosa but cannot be generally recommended, fluoxetine is approved in bulimia nervosa, and lisdexamfetamine has been approved for binge-eating disorder in some countries, although not the UK. Inpatient care and family involvement are important in the management of anorexia nervosa.</p></div>","PeriodicalId":74157,"journal":{"name":"Medicine (Abingdon, England : UK ed.)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Eating disorders\",\"authors\":\"\",\"doi\":\"10.1016/j.mpmed.2024.05.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Eating disorders are common, affecting 5–10% of young people, with &gt;50% of these having an illness that persists for &gt;5 years. The main eating disorders are anorexia nervosa, bulimia nervosa and binge-eating disorder. Eating disorders with binge eating now dominate. New diagnostic categories have been introduced (avoidant/restrictive food intake disorder, pica, rumination disorder). Genetic factors interacting with environmental stress (some shared with other psychiatric disorders, others relating to metabolism and eating) increase the risk. Self-management strategies, including a focus on social emotional functioning and behavioural change skills to manage fears and habits, are moderately effective. Olanzapine shows some evidence in anorexia nervosa but cannot be generally recommended, fluoxetine is approved in bulimia nervosa, and lisdexamfetamine has been approved for binge-eating disorder in some countries, although not the UK. Inpatient care and family involvement are important in the management of anorexia nervosa.</p></div>\",\"PeriodicalId\":74157,\"journal\":{\"name\":\"Medicine (Abingdon, England : UK ed.)\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine (Abingdon, England : UK ed.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1357303924001294\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine (Abingdon, England : UK ed.)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1357303924001294","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

饮食失调症很常见,5-10% 的年轻人会患上饮食失调症,其中 50%的人患病时间长达 5 年。主要的饮食失调症有神经性厌食症、神经性贪食症和暴饮暴食症。暴饮暴食的饮食失调症目前占主导地位。已经引入了新的诊断类别(回避/限制性食物摄入障碍、偏食、反刍障碍)。遗传因素与环境压力相互作用(有些与其他精神疾病相同,有些则与新陈代谢和饮食有关),增加了患病风险。自我管理策略,包括关注社会情绪功能和行为改变技能,以控制恐惧和习惯,效果一般。奥氮平(Olanzapine)对神经性厌食症有一定疗效,但一般不推荐使用;氟西汀(Fluoxetine)获准用于治疗神经性贪食症;利司他明(Lisdexamfetamine)已在一些国家获准用于治疗暴饮暴食症,但在英国尚未获准。住院治疗和家庭参与对神经性厌食症的治疗非常重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Eating disorders

Eating disorders are common, affecting 5–10% of young people, with >50% of these having an illness that persists for >5 years. The main eating disorders are anorexia nervosa, bulimia nervosa and binge-eating disorder. Eating disorders with binge eating now dominate. New diagnostic categories have been introduced (avoidant/restrictive food intake disorder, pica, rumination disorder). Genetic factors interacting with environmental stress (some shared with other psychiatric disorders, others relating to metabolism and eating) increase the risk. Self-management strategies, including a focus on social emotional functioning and behavioural change skills to manage fears and habits, are moderately effective. Olanzapine shows some evidence in anorexia nervosa but cannot be generally recommended, fluoxetine is approved in bulimia nervosa, and lisdexamfetamine has been approved for binge-eating disorder in some countries, although not the UK. Inpatient care and family involvement are important in the management of anorexia nervosa.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信